MRNS
Marinus Pharmaceuticals Inc

12,026
Loading...
Loading...
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Marinus Pharmaceuticals Inc?
What is the 52-week high for Marinus Pharmaceuticals Inc?
What is the 52-week low for Marinus Pharmaceuticals Inc?
What is Marinus Pharmaceuticals Inc stock price today?
What was Marinus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Marinus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Marinus Pharmaceuticals Inc?
What is the 50-day moving average of Marinus Pharmaceuticals Inc?

Latest MRNS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.